Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3016605rdf:typepubmed:Citationlld:pubmed
pubmed-article:3016605lifeskim:mentionsumls-concept:C0031117lld:lifeskim
pubmed-article:3016605lifeskim:mentionsumls-concept:C0268381lld:lifeskim
pubmed-article:3016605lifeskim:mentionsumls-concept:C0085084lld:lifeskim
pubmed-article:3016605lifeskim:mentionsumls-concept:C0220912lld:lifeskim
pubmed-article:3016605lifeskim:mentionsumls-concept:C0220913lld:lifeskim
pubmed-article:3016605pubmed:issue8lld:pubmed
pubmed-article:3016605pubmed:dateCreated1986-9-17lld:pubmed
pubmed-article:3016605pubmed:abstractTextA 51-year-old man had primary amyloidosis, with typical amyloid neuropathy and signs of motor neuron disease, including widespread fasciculation in limb muscles, tongue atrophy and fasciculation, swallowing and chewing difficulty, symmetric hyperreflexia, and bilateral Hoffmann's signs. Fasciculations, fibrillations, and positive sharp waves were found in electromyography of all muscles tested. Motor nerve conduction velocities were moderately slow. Lambda chains were detected in serum and CSF. Amyloid was found in sural nerve biopsy. This combination of amyloid neuropathy and features of amyotrophic lateral sclerosis is related to the motor neuron disease of plasma cell dyscrasias.lld:pubmed
pubmed-article:3016605pubmed:languageenglld:pubmed
pubmed-article:3016605pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3016605pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3016605pubmed:statusMEDLINElld:pubmed
pubmed-article:3016605pubmed:monthAuglld:pubmed
pubmed-article:3016605pubmed:issn0028-3878lld:pubmed
pubmed-article:3016605pubmed:authorpubmed-author:AbarbanelJ...lld:pubmed
pubmed-article:3016605pubmed:authorpubmed-author:FrisherSSlld:pubmed
pubmed-article:3016605pubmed:authorpubmed-author:OsimaniAAlld:pubmed
pubmed-article:3016605pubmed:issnTypePrintlld:pubmed
pubmed-article:3016605pubmed:volume36lld:pubmed
pubmed-article:3016605pubmed:ownerNLMlld:pubmed
pubmed-article:3016605pubmed:authorsCompleteYlld:pubmed
pubmed-article:3016605pubmed:pagination1125-7lld:pubmed
pubmed-article:3016605pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:meshHeadingpubmed-meshheading:3016605-...lld:pubmed
pubmed-article:3016605pubmed:year1986lld:pubmed
pubmed-article:3016605pubmed:articleTitlePrimary amyloidosis with peripheral neuropathy and signs of motor neuron disease.lld:pubmed
pubmed-article:3016605pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3016605pubmed:publicationTypeCase Reportslld:pubmed